10.74
price down icon0.56%   -0.06
after-market Dopo l'orario di chiusura: 10.64 -0.10 -0.93%
loading
Precedente Chiudi:
$10.80
Aprire:
$10.5
Volume 24 ore:
24,922
Relative Volume:
0.26
Capitalizzazione di mercato:
$57.47M
Reddito:
$7.97M
Utile/perdita netta:
$-75.74M
Rapporto P/E:
-0.4422
EPS:
-24.2853
Flusso di cassa netto:
$-85.33M
1 W Prestazione:
-2.89%
1M Prestazione:
+34.25%
6M Prestazione:
-25.10%
1 anno Prestazione:
-8.52%
Intervallo 1D:
Value
$10.01
$10.77
Intervallo di 1 settimana:
Value
$10.01
$11.19
Portata 52W:
Value
$3.76
$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
Nome
Aligos Therapeutics Inc
Name
Telefono
(800) 466-6059
Name
Indirizzo
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
Dipendente
70
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
ALGS's Discussions on Twitter

Confronta ALGS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALGS
Aligos Therapeutics Inc
10.74 73.82M 7.97M -75.74M -85.33M -24.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-18 Ripresa H.C. Wainwright Buy
2024-08-19 Iniziato H.C. Wainwright Buy
2023-01-06 Aggiornamento Jefferies Hold → Buy
2023-01-06 Aggiornamento Piper Sandler Neutral → Overweight
2022-03-23 Downgrade Piper Sandler Overweight → Neutral
2022-01-07 Downgrade JP Morgan Overweight → Neutral
2022-01-06 Downgrade Jefferies Buy → Hold
2021-09-09 Iniziato SVB Leerink Outperform
2021-05-17 Ripresa Piper Sandler Overweight
2020-11-10 Iniziato Cantor Fitzgerald Overweight
2020-11-10 Iniziato JP Morgan Overweight
2020-11-10 Iniziato Jefferies Buy
2020-11-10 Iniziato Piper Sandler Overweight
Mostra tutto

Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie

pulisher
Sep 03, 2025

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting - The Manila Times

Sep 03, 2025
pulisher
Sep 03, 2025

Breakthrough HBV Drug Shows Direct cccDNA Reduction: Aligos Therapeutics Unveils Game-Changing Results - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Aligos Therapeutics Inc. stock trend outlook and recovery path2025 Year in Review & Smart Money Movement Tracker - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Aligos Therapeutics describes new PD-1/PD-L1 interaction inhibitors - BioWorld MedTech

Sep 03, 2025
pulisher
Sep 03, 2025

How to monitor Aligos Therapeutics Inc. with trend dashboardsIndex Update & Advanced Swing Trade Entry Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Aligos Therapeutics Inc.’s volatility index tracking explainedMarket Activity Recap & Real-Time Volume Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What does recent volatility data suggest for Aligos Therapeutics Inc.2025 Stock Rankings & Community Consensus Stock Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Intraday pattern recognizer results for Aligos Therapeutics Inc.2025 Trading Recap & Growth Focused Entry Reports - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Aligos Therapeutics Inc. stock trendline breakdownJuly 2025 Final Week & Weekly Top Performers Watchlists - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Real time breakdown of Aligos Therapeutics Inc. stock performanceBear Alert & Daily Market Momentum Tracking - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times

Sep 02, 2025
pulisher
Sep 02, 2025

Clinical-Stage Liver Disease Developer Aligos Therapeutics to Share Updates at Global Investment Conference - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

What chart patterns are forming on Aligos Therapeutics Inc.Quarterly Portfolio Report & AI Enhanced Trading Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can a trend reversal in Aligos Therapeutics Inc. lead to recoveryQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Combining price and volume data for Aligos Therapeutics Inc.Market Activity Summary & Real-Time Volume Analysis Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Aligos Therapeutics Inc. bounce back from current supportJuly 2025 Volume & Consistent Profit Trading Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Risk vs reward if holding onto Aligos Therapeutics Inc.2025 Price Action Summary & Long-Term Growth Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Heatmap analysis for Aligos Therapeutics Inc. and competitorsMarket Growth Report & Smart Allocation Stock Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Candlestick signals on Aligos Therapeutics Inc. stock todayMarket Risk Report & Smart Investment Allocation Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What’s next for Aligos Therapeutics Inc. stock priceGap Down & Low Drawdown Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Short interest data insights for Aligos Therapeutics Inc.Market Sentiment Summary & AI Optimized Trading Strategy Guides - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Aligos Therapeutics Inc. stock undervalued right nowStock Surge & Fast Exit/Entry Strategy Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What’s the fair value of Aligos Therapeutics Inc. stockJuly 2025 Rallies & Stock Market Timing Techniques - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Will Aligos Therapeutics Inc. benefit from geopolitical trendsQuarterly Market Review & Risk Controlled Stock Pick Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Aligos Therapeutics Inc. stock momentum explainedWeekly Risk Summary & AI Optimized Trading Strategy Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Aligos Therapeutics Inc. Breakout Confirmed by Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Sep 01, 2025

Will Aligos Therapeutics Inc. outperform tech stocksWeekly Gains Summary & Intraday High Probability Setup Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Will Aligos Therapeutics Inc. continue its uptrendInsider Buying & Weekly Stock Performance Updates - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Backtesting results for Aligos Therapeutics Inc. trading strategies2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Evaluating Aligos Therapeutics Inc. with trendline analysis2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Reversal indicators forming on Aligos Therapeutics Inc. stockCPI Data & High Return Stock Watch Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Why Aligos Therapeutics Inc. stock attracts strong analyst attentionMarket Activity Recap & Weekly Sector Rotation Insights - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Best data tools to analyze Aligos Therapeutics Inc. stockMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What is the target price for Aligos Therapeutics Inc. stockMarket Activity Report & AI Enhanced Trading Alerts - sundaytimes.kr

Aug 31, 2025
pulisher
Aug 31, 2025

Aligos Therapeutics Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 31, 2025
pulisher
Aug 31, 2025

Will Aligos Therapeutics Inc. stock go up soonStop Loss & Low Drawdown Investment Strategies - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Can you recover from losses in Aligos Therapeutics Inc.July 2025 Intraday Action & Fast Gain Stock Tips - Newser

Aug 30, 2025

Aligos Therapeutics Inc Azioni (ALGS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):